Bextra Drug Recall Lawyers

Tulsa, Norman, Edmond, Oklahoma City, and McAlester, Oklahoma

Schedule Your
Free Consultation

extra is a form of non-steroidal anti-inflammatory drug (NSAID) known as a COX-2 inhibitor, similar in structure to Vioxx. It has been approved for the treatment of osteoarthritis, rheumatoid arthritis, and severe menstrual pain. Some studies have pointed to a possible risk of heart attack and stroke among coronary bypass surgery patients who take Bextra. Unlike Vioxx, there is no evidence supporting that taking Bextra is an independent risk factor for heart attack and stroke, but there is evidence that this potentially defective drug was developed and marketed for profit rather than as a beneficial treatment.

In a 2007 meta-study published in the Journal of the American Medical Association, doctors found that there was no reason to suspect that all COX-2 inhibitors exhibited the same risk factors. The meta-study looked at the results of over 114 studies that included over 100,000 patients and determined that only Vioxx was responsible for increased likelihood of heart arrhythmias and kidney damage. Other COX-2 inhibitors were found to have no statistically significant increased risk factors.

Voluntary Withdrawal

However, shortly after Vioxx was withdrawn and the results from the small, short-term studies of Bextra seemed to indicate that COX-2 inhibitors might have a class effect of cardiovascular "adverse events," Bextra seemed to be among the worst. In addition, other problems such as serious skin reactions such as toxic epidermal necrolysis (TEN) and Stevens-Johnson Syndrome (SJS), led FDA scientists to conclude that Bextra, which offered no "unique advantages over the other available NSAIDs" should be withdrawn.

A Piece of the Action

If Bextra had nothing to offer, why was it developed, and why was it prescribed? Because drugs are patented, if a different pharmaceutical company wants to get involved in a profitable market dominated by a competitor, it must develop its own unique product with similar effects. Bextra was designed with a similar chemical structure to the profitable Vioxx, not to give you a better treatment, but to give Pfizer a piece of the big-profit NSAID market. Unfortunately, many people were injured as a result of this poorly conceived, poorly tested, but well-marketed drug.

If you or a loved one has been injured as a result of taking Bextra, you deserve compensation. To learn whether you have a case, schedule a defective drug consultation with the pharmaceutical injury lawyers at Stipe, Harper, Laizure, Uselton, Belote, Maxcey, & Thetford today.

Over 50 Years and Growing Strong

– Stipe Law Firm

Welcome to The Stipe Law website, please upgrade your Flash Plugin and enable JavaScript.

McAlester Office
343 E. Carl Albert Pkwy.
McAlester, OK 74501

Phone: (918) 423-0421
or (800) 658-1596
Fax: (918) 423-0266

Oklahoma City Office
525 Central Park Dr., 101
Oklahoma City, OK 73105

Phone: (405) 524-2268
or (800) 299-7299
Fax: (405) 525-3231

Tulsa Office
2417 E. Skelly Dr.
Tulsa, OK 74170

Phone: (918) 749-0749
or (800) 798-2613
Fax: (918) 747-0751

Disclaimer: The information contained throughout this site is meant to generally inform the reader about our areas of practice, including drug recall. This information is not meant to be taken as legal advice and nothing on this site establishes a lawyer / client relationship. Our accident lawyers provide legal assistance in the Tulsa area including Oklahoma City, McAlester and Norman, Oklahoma.